Market Cap 92.15M
Revenue (ttm) 70,000.00
Net Income (ttm) -84.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -121,357.14%
Debt to Equity Ratio 0.00
Volume 2,590,464
Avg Vol 2,491,120
Day's Range N/A - N/A
Shares Out 82.27M
Stochastic %K 33%
Beta 1.49
Analysts Sell
Price Target $5.86

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 440 4200
Address:
660 West Germantown Pike, Suite 110, Plymouth Meeting, United States
jabramowitz
jabramowitz Jul. 1 at 6:50 PM
$INO volume
0 · Reply
joeddie23
joeddie23 Jul. 1 at 6:47 PM
$INO always thought this was where we ended up https://www.linkedin.com/posts/jerome-kim-70119424_today-i-had-the-opportunity-to-speak-at-the-ugcPost-7478080334442541056-_OLw/?utm_source=share&utm_medium=member_ios&rcm=ACoAAAZX2HEB62sKQKSqjmfYavwqK_8X09LfOBc
0 · Reply
BentleyT99
BentleyT99 Jul. 1 at 6:33 PM
$INO This Is A Game Changer In A Multi Billion Dollar Market....INOVIO's Close Relationship With Wistar Is Very Prestigious !!!
0 · Reply
Nordica
Nordica Jul. 1 at 4:53 PM
4 · Reply
Dardpro
Dardpro Jul. 1 at 4:53 PM
$INO I'll give them trillions bro no problem. Buy 🤑😭🤣
0 · Reply
Dardpro
Dardpro Jul. 1 at 4:52 PM
$INO oh yeah babyyyy 💲🤑
0 · Reply
Jrtreats
Jrtreats Jul. 1 at 4:51 PM
$INO very few short shares available for the pos shorts!
0 · Reply
Jrtreats
Jrtreats Jul. 1 at 4:42 PM
$INO I think we have 2 more months of this and then the shorts loose control. So use this time against them. Lock load hold! Thier worst nightmare. Check out thier fees on SLS where they over played thier hands. Short fees around 120% and short interest still about 20%. 😆
1 · Reply
PumperBoatGuy
PumperBoatGuy Jul. 1 at 3:11 PM
$INO new FDA leadership going to approve
0 · Reply
PumperBoatGuy
PumperBoatGuy Jul. 1 at 3:10 PM
$INO 1 million volume already
0 · Reply
Latest News on INO
Inovio Pharmaceuticals Transcript: AGM 2026

May 20, 2026, 9:00 AM EDT - 6 weeks ago

Inovio Pharmaceuticals Transcript: AGM 2026


Inovio Pharmaceuticals Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 6 weeks ago

Inovio Pharmaceuticals Earnings Call Transcript: Q1 2026


Inovio Pharmaceuticals Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 6 weeks ago

Inovio Pharmaceuticals Quarterly report: Q1 2026


Inovio Pharmaceuticals Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 6 weeks ago

Inovio Pharmaceuticals Earnings release: Q1 2026


Inovio Pharmaceuticals Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 6 weeks ago

Inovio Pharmaceuticals Slides: Q1 2026


INOVIO to Participate in Upcoming Scientific Conferences

May 8, 2026, 8:05 AM EDT - 7 weeks ago

INOVIO to Participate in Upcoming Scientific Conferences


Inovio Pharmaceuticals Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Inovio Pharmaceuticals Proxy statement: Proxy filing


INOVIO Announces Pricing of $17.5 Million Public Offering

Apr 2, 2026, 8:55 AM EDT - 3 months ago

INOVIO Announces Pricing of $17.5 Million Public Offering


INOVIO Announces Proposed Public Offering

Apr 1, 2026, 8:05 PM EDT - 3 months ago

INOVIO Announces Proposed Public Offering


INOVIO to Participate in Upcoming Scientific Conference

Apr 1, 2026, 10:29 AM EDT - 3 months ago

INOVIO to Participate in Upcoming Scientific Conference


Inovio Pharmaceuticals Slides: Corporate presentation

Mar 23, 2026, 8:00 AM EDT - 3 months ago

Inovio Pharmaceuticals Slides: Corporate presentation


Inovio Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2025


Inovio Pharmaceuticals Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

Inovio Pharmaceuticals Earnings release: Q4 2025


Inovio Pharmaceuticals Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

Inovio Pharmaceuticals Annual report: Q4 2025


Inovio Pharmaceuticals Slides: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 3 months ago

Inovio Pharmaceuticals Slides: Q4 2025


Inovio, Akeso announce clinical collaboration

2026-03-04T13:15:14.000Z - 4 months ago

Inovio, Akeso announce clinical collaboration


Inovio announces U.S. FDA accepted BLA for INO-3107

2025-12-29T13:10:42.000Z - 6 months ago

Inovio announces U.S. FDA accepted BLA for INO-3107


INOVIO Reports Inducement Grant Under Inducement Plan

Dec 19, 2025, 4:05 PM EST - 6 months ago

INOVIO Reports Inducement Grant Under Inducement Plan


INOVIO to Participate in December Investor Conferences

Nov 18, 2025, 8:05 AM EST - 8 months ago

INOVIO to Participate in December Investor Conferences


Inovio price target raised to $6 from $5 at Piper Sandler

2025-11-14T11:45:36.000Z - 8 months ago

Inovio price target raised to $6 from $5 at Piper Sandler


Inovio 13.16M share Spot Secondary priced at $1.90

2025-11-11T13:45:25.000Z - 8 months ago

Inovio 13.16M share Spot Secondary priced at $1.90


INOVIO Announces Pricing of $25 Million Public Offering

Nov 11, 2025, 8:40 AM EST - 8 months ago

INOVIO Announces Pricing of $25 Million Public Offering


Inovio announces common stock offering, no amount given

2025-11-10T23:20:12.000Z - 8 months ago

Inovio announces common stock offering, no amount given


Inovio Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q3 2025


Inovio Pharmaceuticals Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Earnings release: Q3 2025


Inovio Pharmaceuticals Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Quarterly report: Q3 2025


Inovio Pharmaceuticals Slides: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Slides: Q3 2025


Inovio completes rolling submission of BLA for INO-3107

2025-11-03T13:10:55.000Z - 8 months ago

Inovio completes rolling submission of BLA for INO-3107


Inovio Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q2 2025


Inovio Pharmaceuticals Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Earnings release: Q2 2025


Inovio Pharmaceuticals Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Quarterly report: Q2 2025


INOVIO to Present at Upcoming Scientific Conference

Jul 7, 2025, 4:05 PM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific Conference


Inovio Pharmaceuticals Slides: Corporate Presentation

Jun 17, 2025, 7:00 AM EDT - 1 year ago

Inovio Pharmaceuticals Slides: Corporate Presentation


Inovio Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q1 2025


Inovio Pharmaceuticals Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings release: Q1 2025


Inovio Pharmaceuticals Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Quarterly report: Q1 2025


INOVIO to Present at Upcoming Scientific Conferences

Apr 9, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific Conferences


Inovio Pharmaceuticals Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Inovio Pharmaceuticals Proxy statement: Proxy Filing


Inovio Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2024


Inovio Pharmaceuticals Earnings release: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings release: Q4 2024


Inovio Pharmaceuticals Annual report: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Annual report: Q4 2024


jabramowitz
jabramowitz Jul. 1 at 6:50 PM
$INO volume
0 · Reply
joeddie23
joeddie23 Jul. 1 at 6:47 PM
$INO always thought this was where we ended up https://www.linkedin.com/posts/jerome-kim-70119424_today-i-had-the-opportunity-to-speak-at-the-ugcPost-7478080334442541056-_OLw/?utm_source=share&utm_medium=member_ios&rcm=ACoAAAZX2HEB62sKQKSqjmfYavwqK_8X09LfOBc
0 · Reply
BentleyT99
BentleyT99 Jul. 1 at 6:33 PM
$INO This Is A Game Changer In A Multi Billion Dollar Market....INOVIO's Close Relationship With Wistar Is Very Prestigious !!!
0 · Reply
Nordica
Nordica Jul. 1 at 4:53 PM
4 · Reply
Dardpro
Dardpro Jul. 1 at 4:53 PM
$INO I'll give them trillions bro no problem. Buy 🤑😭🤣
0 · Reply
Dardpro
Dardpro Jul. 1 at 4:52 PM
$INO oh yeah babyyyy 💲🤑
0 · Reply
Jrtreats
Jrtreats Jul. 1 at 4:51 PM
$INO very few short shares available for the pos shorts!
0 · Reply
Jrtreats
Jrtreats Jul. 1 at 4:42 PM
$INO I think we have 2 more months of this and then the shorts loose control. So use this time against them. Lock load hold! Thier worst nightmare. Check out thier fees on SLS where they over played thier hands. Short fees around 120% and short interest still about 20%. 😆
1 · Reply
PumperBoatGuy
PumperBoatGuy Jul. 1 at 3:11 PM
$INO new FDA leadership going to approve
0 · Reply
PumperBoatGuy
PumperBoatGuy Jul. 1 at 3:10 PM
$INO 1 million volume already
0 · Reply
tau72
tau72 Jul. 1 at 3:04 PM
$INO Moron who kept shorting INO stock will soon suffering from cancer/disease the rest of his/her life.
1 · Reply
HARM20
HARM20 Jul. 1 at 1:57 PM
$INO Looking good! Do we have a breakout in progress!
4 · Reply
Jrtreats
Jrtreats Jul. 1 at 9:09 AM
$INO if management would figure out a way to increase cash runway one time without diluting shareholders, I think the share price skyrocket$. Be a little creative, don't always choose the easy route and show a little appreciation too us longs one time!! We have supported the company for a long time now. Shea, you can do it. Make a great deal for us all!
2 · Reply
updownsides
updownsides Jul. 1 at 5:16 AM
$INO ZERO FACTS. Conspiracy theories are not changing what's happening. Inovio is in deep waters. Never been this low on cash. Obviously the FDA is ignoring their pleas for a meeting to discuss accelerated approval. No money coming in for a very long time if ever. Beaten to market in China with APL-1702 and in the USA with Papzimeos. Show me the value when other companies are commercialized now for the same non approved therapies Inovio is depending on.
1 · Reply
uStrange
uStrange Jun. 30 at 10:02 PM
$INO my belief: Deep Pockets with a vested interest in the Delay/Destruction of DNA-Medicine….aka BP ($34K is “chump-change” for their Business Model)
2 · Reply
tomonota
tomonota Jun. 30 at 8:59 PM
$INO Someone shorted INO at $1.10 with 2,000 puts expiring Thursday, at $0.17/share, or -$34,000, and after the close the shares traded up at $1.12. Odds are the short does not have the cash to spend $220,000 on a losing bet., making me wonder why they do it to themselves, these short fools who must know they won't see INO close at $1.00. Not in July 2026 for sure. The point of a losing trade is what? A Pyrrhic victory if you go broke doing it. Why would someone so persistently blow his wad on losing trades to short this stock? Any explanation for this kamikaze behavior?
0 · Reply
updownsides
updownsides Jun. 30 at 7:51 PM
$INO @BentleyT99 They haven't even released the trial results for VGX-3100. Then submission, and acceptance later. It took APL-1702 2-1/2 years to get China approval after unblinding for the same indication. 2028 before any income if ever approved and once again beat to market by a mile. Ino-3107 will receive a CRL by end if October delaying again for years. If by a miracle it gets approved, cash will start to trickle in 2027. Will be step therapy if ever approved so only after treated with Papzimeos first. Zero cash in 2026. Maybe end of 2027. Come back in 2028.
1 · Reply
23Cazzy
23Cazzy Jun. 30 at 7:28 PM
$INO Where art thou , tomato 🍅?
0 · Reply
jabramowitz
jabramowitz Jun. 30 at 4:41 PM
$INO should be 10$ plus...
1 · Reply
dogbone98
dogbone98 Jun. 30 at 4:39 PM
$INO Since people here love INO's China trials: https://finance.yahoo.com/news/exclusive-us-house-committee-opens-100330881.html
1 · Reply
RaphaelRapoport
RaphaelRapoport Jun. 30 at 3:41 PM
$INO real talk should I re-enter here? I just dont get what next catalyst date is and likelihood of it happening
1 · Reply
GermanBulle
GermanBulle Jun. 30 at 3:20 PM
$INO this stock this share price this management
0 · Reply